ced-4 encodes the central adaptor of the C. elegans apoptosis pathway. Analogous to mammalian APAF1, CED-4 nucleates a caspase-activation platform (the apoptosome) that drives CED-3 maturation and downstream substrate cleavage. As such, ced-4 is the linchpin between the regulatory triad (EGL-1 / CED-9) and the executioner CED-3.
CD BioSciences provides an optimized, full-stack CRISPR/Cas9 platform for C. elegans. We design and deliver custom ced-4 alleles — including targeted knockouts, fluorescent or epitope tag knockins, and site-specific point mutations — with complete genotype verification and a transparent reporting package.
| Gene symbol | ced-4 (Apoptosis activator (Apaf-1 homolog)) |
|---|---|
| Protein product | CED-4 — Apaf-1-like apoptosis adaptor |
| Mammalian homolog | APAF1 (mammalian Apaf-1) |
| Biological role | Adaptor that scaffolds CED-3 caspase activation; core component of the C. elegans apoptosome-like complex. |
| Loss-of-function phenotype | Loss of ced-4 blocks essentially all programmed somatic cell deaths; animals viable with extra cells. |
| Why edit it | Foundational model for apoptosome assembly, intrinsic (mitochondrial) apoptosis, and cancer drug resistance linked to apoptosome defects. |
| Recommended background | N2 (wild type); can be crossed into reporter or co-CRISPR selection backgrounds. |
| Representative allele | Standard knockout (ok / tm / gk series); reference alleles widely available. |
ced-4 at a glance: blocks essentially all programmed somatic cell deaths; a clean Apaf-1-like apoptosis-deficient model. Editing ced-4 alone is a powerful way to dissect CED-4 function in vivo, with conserved relevance to human APAF1 biology.
gRNA-guided Cas9 cutting with NHEJ repair to introduce frameshift indels, generating premature stop codons and null / strong-loss-of-function ced-4 alleles.
Homology-directed repair (HDR) inserts GFP / HA / FLAG or other tags at the ced-4 locus for endogenous expression and subcellular localization studies.
Introduce specific amino-acid substitutions to dissect functional domains and separate catalytic from scaffolding roles of CED-4.
Build tissue-specific or inducible configurations and reporter lines for spatiotemporal analysis of CED-4 function.
Define target (knockout / knockin / point mutation), select gRNA(s) and HDR template, confirm against the latest genome build.
Design, validate, and synthesize high-specificity guide RNAs targeting the ced-4 locus.
Build Cas9 / gRNA delivery construct and, for knockin, the homology-arm repair template.
Perform gonadal microinjection of N2 animals with CRISPR components and co-CRISPR selection markers.
PCR, Sanger / sequencing, and phenotype confirmation to isolate edited animals and verify alleles.
Provide homozygous / balanced ced-4 strains plus a full genotype and methods report.
Standard knockout projects deliver a frameshift indel allele predicted to produce a premature stop and a loss-of-function phenotype. We confirm the edit by sequencing and, where relevant, by characteristic phenotype assays.
Yes. Using HDR with a designed repair template, we can insert GFP, HA, or FLAG tags at the C- or N-terminus while preserving endogenous promoter and regulation.
Timelines vary with editing type and validation needs, but our optimized pipeline and co-CRISPR selection typically shorten turnaround versus conventional approaches. Contact us with your design for a project-specific estimate.
No. ced-4 loss-of-function animals are viable and fertile, but they retain the 131 cells that normally die during development. This mirrors Apaf-1 knockout in mammals, making ced-4 an exceptionally clean genetic null.
CD BioSciences is committed to convenient, efficient, and cost-effective C. elegans model customization. Tell us your target design — knockout, knockin, tagging, or point mutation — and our scientists will respond with a tailored plan and quote.
Contact UsReferences
1. Kim H. M., Colaiácovo M. P. CRISPR-Cas9-guided genome engineering in C. elegans. Current Protocols in Molecular Biology, 2016, 115(1): 31.7.1–31.7.18.
2. Riedl S. J., Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol, 2004, 5(11): 897-907.
For research use only.
Copyright © 2026 CD BioSciences. All rights reserved.